🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of acetaminophen, asserting the corporations hid potential risks that the pain reliever posed to children's brain development.

The court filing comes four weeks after President Donald Trump promoted an unverified association between consuming acetaminophen - also known as acetaminophen - during pregnancy and autism in young ones.

Paxton is suing J&J, which previously sold the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a statement, he said they "betrayed America by profiting off of discomfort and promoting medication ignoring the potential hazards."

Kenvue states there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening millions to increase profits," Paxton, a Republican, declared.

Kenvue stated officially that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the welfare of US mothers and children."

On its official site, Kenvue also stated it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a proven link between taking paracetamol and autism."

Groups speaking for physicians and healthcare providers agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to address discomfort and elevated temperature, which can present major wellness concerns if left untreated.

"In more than two decades of research on the use of acetaminophen in pregnancy, not a single reputable study has definitively established that the use of acetaminophen in any trimester of gestation results in neurodevelopmental disorders in offspring," the group stated.

This legal action mentions current declarations from the former administration in asserting the drug is allegedly unsafe.

In recent weeks, Trump raised alarms from public health officials when he told expectant mothers to "struggle intensely" not to consume Tylenol when sick.

The US Food and Drug Administration then published an announcement that physicians should think about restricting the use of acetaminophen, while also stating that "a direct connection" between the medication and autism in children has not been proven.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to conduct "comprehensive study program" that would determine the source of autism spectrum disorder in a limited time.

But authorities cautioned that discovering a unique factor of autism spectrum disorder - believed by scientists to be the result of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and disability that affects how individuals encounter and relate to the world, and is recognized using medical professional evaluations.

In his legal document, Paxton - aligned with the former president who is campaigning for US Senate - claims Kenvue and J&J "intentionally overlooked and tried to quiet the research" around paracetamol and autism.

The lawsuit seeks to make the firms "destroy any marketing or advertising" that asserts acetaminophen is reliable for pregnant women.

The court case parallels the complaints of a group of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in recently.

A federal judge dismissed the legal action, saying studies from the plaintiffs' authorities was inconclusive.